Esmée Oussoren

1.2k citations

32 papers · 768 indexed · h-index 15

Physiology top 5%
- Lysosomal Storage Disorders Research 18
Clinical Biochemistry top 5%
- Metabolism and Genetic Disorders 9
Rheumatology top 5%
- Glycogen Storage Diseases and Myoclonus 8
Pharmacy top 10%
- Oral and gingival health research 2
Biochemistry top 10%
Epidemiology
- Trypanosoma species research and implications 5
Organic Chemistry
- Carbohydrate Chemistry and Synthesis 4
Genetics
- Neurogenetic and Muscular Disorders Research 3
Pediatrics, Perinatology and Child Health
- Neonatal Health and Biochemistry 2

Co-authors: Ans T. van der Ploeg George J. G. Ruijter Marion M. Brands W.W.M. Pim Pijnappel Arnold Reuser Wim C.J. Hop Frank Baas P.A. Voûte
Cited by: Physiology Clinical Biochemistry Rheumatology
Journals: Blood (1 paper)PLoS ONE (1 paper)Biochemical and Biophysical Research Communications (1 paper)
Partner nations: Netherlands United States Germany

In The Last Decade

Esmée Oussoren

32 papers receiving 752 citations

Peers

Countries citing papers authored by Esmée Oussoren

Since Specialization

Citations

This map shows the geographic impact of Esmée Oussoren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esmée Oussoren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esmée Oussoren more than expected).

Fields of papers citing papers by Esmée Oussoren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esmée Oussoren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esmée Oussoren. The network helps show where Esmée Oussoren may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Esmée Oussoren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Esmée Oussoren Line = papers co-authored together Esmée Oussoren links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Social cognition, emotion regulation and social competence in classical galactosemia patients without intellectual disability Acta Neuropsychiatrica ·Merel E. Hermans,Gert J. Geurtsen,Carla E. M. Hollak,Mirian C. H. Janssen,Janneke G. Langendonk,Valerie L.V. Merckelbach,Esmée Oussoren,Kim J. Oostrom,Annet M. Bosch	2024	1
2	Analysis of urinary oligosaccharide excretion patterns by UHPLC/HRAM mass spectrometry for screening of lysosomal storage disorders Journal of Inherited Metabolic Disease ·Marne C. Hagemeijer,Jeroen C. van den Bosch,Michiel Bongaerts,Edwin H. Jacobs,Johanna M. P. van den Hout,Esmée Oussoren,George J. G. Ruijter	2023	5
3	Modeling cartilage pathology in mucopolysaccharidosis VI using iPSCs reveals early dysregulation of chondrogenic and metabolic gene expression Frontiers in Bioengineering and Biotechnology ·Mike Broeders,Jgj van Rooij,Esmée Oussoren,Tjm van Gestel,C. A. Smith,Sj Kimber,Rm Verdijk,Maem Wagenmakers,J. van den Hout,At van der Ploeg,Roberto Narcisi,Wwmp Pijnappel	2022	4
4	Effect of Anti-Iduronate 2-Sulfatase Antibodies in Patients with Mucopolysaccharidosis Type II Treated with Enzyme Replacement Therapy The Journal of Pediatrics ·Audrey A.M. Vollebregt,Marianne Hoogeveen‐Westerveld,George J. G. Ruijter,Hannerieke van den Hout,Esmée Oussoren,Ans T. van der Ploeg,W.W.M. Pim Pijnappel	2022	1
5	Mucolipidosis type II and type III: a systematic review of 843 published cases Genetics in Medicine ·Emma J. Dogterom,Margreet A.E.M. Wagenmakers,Martina Wilke,Serwet Demirdas,Nicole Muschol,Sandra Pohl,Jan C. van der Meijden,Dimitris Rizopoulos,Ans T. van der Ploeg,Esmée Oussoren	2021	15
6	Using Out-of-Batch Reference Populations to Improve Untargeted Metabolomics for Screening Inborn Errors of Metabolism Metabolites ·Michiel Bongaerts,Ramon Bonte,Serwet Demirdas,Edwin H. Jacobs,Esmée Oussoren,Ans van der Ploeg,Margreet A. E. M. Wagenmakers,Robert M.W. Hofstra,Henk J. Blom,Marcel Reinders,George J. G. Ruijter	2020	12
7	Treating neutropenia and neutrophil dysfunction in glycogen storage disease type Ib with an SGLT2 inhibitor Blood ·Saskia B. Wortmann,Johan L.K. Van Hove,Terry G. J. Derks,Nathalie Chevalier,Vijaya Knight,Andreas Koller,Esmée Oussoren,Johannes A. Mayr,Francjan J. van Spronsen,Florian B. Lagler,Sommer Gaughan,Emile Van Schaftingen,Maria Veiga‐da‐Cunha	2020	93
8	A Generic Assay to Detect Aberrant ARSB Splicing and mRNA Degradation for the Molecular Diagnosis of MPS VI Molecular Therapy — Methods & Clinical Development ·Mike Broeders,Kasper Smits,Busra Goynuk,Esmée Oussoren,Hannerieke J.M.P. van den Hout,Atze J. Bergsma,Ans T. van der Ploeg,W.W.M. Pim Pijnappel	2020	8
9	Classical galactosemia: neuropsychological and psychosocial functioning beyond intellectual abilities Orphanet Journal of Rare Diseases ·Mendy M. Welsink‐Karssies,Kim J. Oostrom,Merel E. Hermans,Carla E. M. Hollak,Mirian C. H. Janssen,Janneke G. Langendonk,Esmée Oussoren,M. Estela Rubio‐Gozalbo,Maaike de Vries,Gert J. Geurtsen,Annet M. Bosch	2020	13
10	Ready for Repair? Gene Editing Enters the Clinic for the Treatment of Human Disease Molecular Therapy — Methods & Clinical Development ·Martijn P. T. Ernst,Mike Broeders,Pablo Herrero-Hernandez,Esmée Oussoren,Ans T. van der Ploeg,W.W.M. Pim Pijnappel	2020	63
11	Hip disease in Mucopolysaccharidoses and Mucolipidoses: A review of mechanisms, interventions and future perspectives Bone ·Esmée Oussoren,Margreet A.E.M. Wagenmakers,Bianca Link,Jan C. van der Meijden,W.W.M. Pim Pijnappel,George J. G. Ruijter,Mirjam Langeveld,Ans T. van der Ploeg	2020	10
12	Gray and white matter are both affected in classical galactosemia: An explorative study on the association between neuroimaging and clinical outcome Molecular Genetics and Metabolism ·Mendy M. Welsink‐Karssies,Anouk Schrantee,Matthan W.A. Caan,Carla E. M. Hollak,Mirian C. H. Janssen,Esmée Oussoren,Maaike C. de Vries,Stefan D. Roosendaal,Marc Engelen,Annet M. Bosch	2020	9
13	A long term follow-up study of the development of hip disease in Mucopolysaccharidosis type VI Molecular Genetics and Metabolism ·Esmée Oussoren,J. H. J. M. Bessems,Virginie Pollet,Jan C. van der Meijden,L. J. van der Giessen,Iris Plug,Annick S. Devos,George J. G. Ruijter,Ans T. van der Ploeg,Mirjam Langeveld	2017	8
14	A Multiplex Assay for the Diagnosis of Mucopolysaccharidoses and Mucolipidoses PLoS ONE ·Eveline J. Langereis,Tom Wagemans,Wim Kulik,Dirk J. Lefeber,Henk van Lenthe,Esmée Oussoren,Ans T. van der Ploeg,George J. G. Ruijter,Ron A. Wevers,Frits A. Wijburg,Naomi van Vlies	2015	30
15	Genetic basis of alpha‐aminoadipic and alpha‐ketoadipic aciduria Journal of Inherited Metabolic Disease ·Jacob Hagen,Heleen te Brinke,Ronald J. A. Wanders,Alida C. Knegt,Esmée Oussoren,A. Jeannette M. Hoogeboom,George J. G. Ruijter,Daniel M. Becker,Karl Otfried Schwab,Ingo Franke,Marinus Durán,Hans R. Waterham,Jörn Oliver Sass,Sander M. Houten	2015	44
16	Residual α-l-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients Molecular Genetics and Metabolism ·Esmée Oussoren,J. L. M. Keulemans,Otto P. van Diggelen,Linda F. Oemardien,Remco G. M. Timmermans,Ans T. van der Ploeg,George J. G. Ruijter	2013	40
17	Up to five years experience with 11 mucopolysaccharidosis type VI patients Molecular Genetics and Metabolism ·Marion M. Brands,Esmée Oussoren,George J. G. Ruijter,Audrey A.M. Vollebregt,Hannerieke M.P. van den Hout,Koen F. M. Joosten,Wim C.J. Hop,Iris Plug,Ans T. van der Ploeg	2013	31
18	Mucopolysaccharidosis: Cardiologic features and effects of enzyme‐replacement therapy in 24 children with MPS I, II and VI Journal of Inherited Metabolic Disease ·Marion M. Brands,Ingrid M.E. Frohn-Mulder,M.L.C. Hagemans,Wim C.J. Hop,Esmée Oussoren,Willem A. Helbing,Ans T. van der Ploeg	2012	60
19	Bone, joint and tooth development in mucopolysaccharidoses: Relevance to therapeutic options Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Esmée Oussoren,Marion M. Brands,George J. G. Ruijter,Ans T. van der Ploeg,Arnold Reuser	2011	77
20	Molecular Cloning of Human MUC3 cDNA Reveals a Novel 59 Amino Acid Tandem Repeat Region Biochemical and Biophysical Research Communications ·B. Jan‐Willem van Klinken,Tanja C. Van Dijken,Esmée Oussoren,Hans A. Büller,Jan P. Dekker,Alexandra W. C. Einerhand	1997	25

About Esmée Oussoren

Esmée Oussoren is a scholar working on Clinical Biochemistry, Physiology and Rheumatology, having authored 32 papers that have together received 768 indexed citations. Recurring topics across this work include Lysosomal Storage Disorders Research (18 papers), Metabolism and Genetic Disorders (9 papers), Glycogen Storage Diseases and Myoclonus (8 papers), Trypanosoma species research and implications (5 papers), Carbohydrate Chemistry and Synthesis (4 papers), Neurogenetic and Muscular Disorders Research (3 papers), Neonatal Health and Biochemistry (2 papers) and Oral and gingival health research (2 papers). The work is most often cited by research in Physiology (383 citations), Clinical Biochemistry (89 citations) and Rheumatology (166 citations). Esmée Oussoren has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Ans T. van der Ploeg, George J. G. Ruijter, Marion M. Brands, W.W.M. Pim Pijnappel, Arnold Reuser, Wim C.J. Hop, Frank Baas, P.A. Voûte, Erwin Pauws and Marjon van Groenigen. Their work appears in journals such as Blood, PLoS ONE and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact